Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy

Cancer is one of the leading causes of death in the industrialized world and represents a tremendous social and economic burden. As conventional therapies fail to provide a sustainable cure for most cancer patients, the emerging unique immune therapeutic approach of bacteria-mediated tumor therapy (...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sebastian Felgner, Dino Kocijancic, Michael Frahm, Ulrike Heise, Manfred Rohde, Kurt Zimmermann, Christine Falk, Marc Erhardt, Siegfried Weiss
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2018-02-01
coleção:	OncoImmunology
Assuntos:	bacteria-mediated tumor therapy e. coli immunization murine tumor model salmonella typhimurium
Acesso em linha:	http://dx.doi.org/10.1080/2162402X.2017.1382791
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!